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ABSTRACT
Motivation: Assigning statistical significance accurately has become
increasingly important as meta data of many types, often assembled
in hierarchies, are constructed and combined for further biological
analyses. Statistical inaccuracy of meta data at any level may
propagate to downstream analyses, undermining the validity of
scientific conclusions thus drawn. From the perspective of mass
spectrometry based proteomics, even though accurate statistics for
peptide identification can now be achieved, accurate protein level
statistics remain challenging.
Results: We have constructed a protein ID method that combines
peptide evidences of a candidate protein based on a rigorous formula
derived earlier; in this formula the database P -value of every peptide
is weighted, prior to the final combination, according to the number
of proteins it maps to. We have also shown that this protein ID
method provides accurate protein level E-value, eliminating the need
of using empirical post-processing methods for type-I error control.
Using a known protein mixture, we find that this protein ID method,
when combined with the Soric´ formula, yields accurate values for
the proportion of false discoveries. In terms of retrieval efficacy, the
results from our method are comparable with other methods tested.
Availability: The source code, implemented in C++ on a linux
system, is available for download at ftp://ftp.ncbi.nlm.nih.gov
/pub/qmbp/qmbp ms/RAId/RAId Linux 64Bit
Contact: yyu@ncbi.nlm.nih.gov
1 INTRODUCTION
Peptide identifications (ID) via mass spectrometry (MS) have
become the central component in modern proteomics; this
component, combined with additional analyses, routinely yields
pragmatic meta data, including protein ID, protein quantification,
protein structure and protein associations (Zhang et al., 2013).
These meta data, especially the associated statistical significance
assignments, need to be as accurate as possible because they often
form the building blocks for investigations at the systems biology
level and influence the scientific conclusions drawn henceforth. In
this paper, we focus on protein ID, in particular on improving the
accuracy of statistical significance assigned to proteins identified.
The need for robust developments towards accurate statistical
significance assignments has been advocated (Noble and MacCoss,
2012; Huang et al., 2012) despite the existence of many protein
ID methods (McHugh and Arthur, 2008; Serang and Noble, 2012;
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Li and Radivojac, 2012). It has also been suggested (Spirin et al.,
2011) that the primary cause of unreliable significance assignment
for protein ID can be attributed to inaccurate significance
assignment for peptide ID. Frequently used error-control/significance-
assigning methods for peptide ID largely fall into two groups:
proportion of false discovery (PFD), which is often incorrectly
termed as false discovery rate (Benjamini and Hochberg, 1995),
and spectrum-specific P -value/E-value (Fenyo and Beavis, 2003;
Alves et al., 2007; Park et al., 2008). Methods belonging to
the first group, controlling type-I error globally only, do not
discriminate among identified peptides (Elias and Gygi, 2007).
Methods belonging to the second group, capable of assigning per-
spectrum per-peptide significance, can properly prioritize identified
peptides when reported P -/E-values are accurate; but the needed
statistical accuracy is often unattainable due to improper heuristics
or unjustifiable distribution assumptions (Alves et al., 2007; Segal,
2008; Spirin et al., 2011).
Given a tandem MS (MS/MS) spectrum and a quality score
cutoff Sc, the E-value E(Sc) should reflect the expected number
of random peptides with scores the same as or better than Sc.
(Similarly, the P -value P (Sc) reflects the probability of finding a
random peptide with quality score S ≥ Sc.) In general, the E-
value is obtained by multiplying the P -value by the total number
of qualified peptides (whose masses fall in the range [mp− δ,mp+
δ] with mp being the precursor ion’s mass and δ the specified
tolerance) in the database searched. Thus, besides providing the user
with the numbers of false positives to anticipate, accurate E-value
assignments enable ranking of candidate peptides across different
spectra and experiments. In database searches in proteomics, the
goal of accurate statistics can be approached in at least two ways.
First, one may devise a scoring function whose resulting score
distribution can be analytically characterized and thus used to
infer the statistical significance (Alves et al., 2007); if this is done
correctly, the theoretical score distribution should fit well the bulk
part of the normalized score histogram obtained from scoring all
qualified peptides in the database of interest. Second, one may infer
the spectrum-specific P -value via the normalized score histogram
obtained from scoring all possible peptides (APP) (Alves and Yu,
2008); in this case, the database dependence appears only in the E-
value, which is the P -value multiplied by the number of qualified
peptides associated with the specified precursor ion mass and mass
error tolerance. Either way yields database-specific E-values. Once
a peptide E-value is obtained, one may transform it into the peptide
database P -value (DPV) (Yu et al., 2006; Alves et al., 2008b),
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representing the likelihood of obtaining, in the database chosen,
at least one peptide scoring equal to or better than the prescribed
threshold. When combining P -values of peptides associated with a
candidate protein, we use the peptides’ DPVs.
Specifically, our proposed protein ID method combines peptide
evidences of a candidate protein using a rigorous formula derived
earlier (Alves and Yu, 2011); in this formula the DPV of every
peptide is weighted, prior to the final combination, according to
the number of proteins it maps to. Among the existing protein ID
methods, the approach taken by Spirin et al. (2011) is closest to
ours; both methods combine peptides’ spectrum-specific P -values.
There are, however, major differences between our method and
that of Spirin et al. (2011). First, in our method, each candidate
peptide of a query spectrum receives a DPV, allowing multiple
matching peptides per spectrum. This is to take into account
the possibility of peptide co-elution (Alves et al., 2008a). For
the method of Spirin et al. (2011), only the best peptide match
per spectrum is considered and the peptide DPV thus represents
the probability of having the best match score no worse than
the prescribed threshold when searching a database. Since each
random protein database only contributes one best match score,
searching many random protein databases is required for the P -
value assignment. Second, the candidate peptides’ P -values are
combined differently. Our method, down-weighting contributions
of peptides mappable to multiple proteins, combines peptide
DPVs directly using a rigorous formula (Alves and Yu, 2011); the
method of Spirin et al. (2011) first transforms, for every candidate
protein, the P -values of its associated peptides into Z-scores,
combines them using Stouffer’s formula (Whitlock, 2005), and then
transforms the combined Z-score back to a final P -value with
multiple hypotheses testing correction. Third, the cutoff conditions
for peptides’ P -values are different. Our method approximates
DPVs (Yu et al., 2006; Alves et al., 2008b) by E-values, valid for
small E-values, and retains all peptides whose E-values are less
than one. That is, we have a global cutoff condition. For the
method of Spirin et al. (2011), the peptide cutoff P -value varies
by candidate protein: given a candidate protein, its corresponding
peptides’ Z-scores are first sorted in descending order; the kth Z-
score is chosen as the cutoff provided that the maximum combined
Z-score is reached while combining the top k Z-scores using the
Stouffer’s formula.
There exist many other protein ID methods, for example,
ProFound (Zhang and Chait, 2000), ProteinProphet (Nesvizhskii et al.,
2003), DBParser (Yang et al., 2004), EBP (Price et al., 2007),
PANORAMICS (Feng et al., 2007), PROVALT (McHugh and Arthur,
2008), X!Tandem (Fenyo et al., 2010), Scaffold (Searle, 2010) and
npCI (Serang et al., 2013), to name just a few. We refer the readers
to recent review papers (Huang et al., 2012; Serang and Noble,
2012) for details and more comprehensive listings of these methods.
Although some of them do start with spectrum-specific peptide
P -values, they often assume certain parametric forms for the
peptide score distributions when searching a random database;
other methods, however, only process outputs of specific peptide
identification tools, limiting their uses to certain platforms. By
discarding all but the best few peptide scores per spectrum per
database search, the method of Spirin et al. (2011) does not
rely on the accuracy of the full peptide score distribution from
searching a random database and in principle can accept input
from various peptide identification tools. Our method is free from
the aforementioned problems for different reasons. Founded on a
derived analytical formula, our method can be applied in general
and will yield accurate protein P -values if the input peptide DPVs
(or E-values) are accurate. When using peptide E-values reported
by RAId DbS, even though the parameters of the score distribution
are determined via maximum-likelihood, the functional form of
the score distribution is analytically derived (Alves et al., 2007)
rather than assumed. When the statistical significances are obtained
from RAId aPS (Alves et al., 2010), for every scoring function
implemented, the P -values are inferred by scoring APP instead
of assuming that the score histogram follows a specific form; the
peptide E-values are then obtained via multiplying the P -values by
the respective numbers of qualified peptides.
The paper is organized as follows. The mathematical underpinnings
of our formalism will be described in the methods section. In the
results section, comparisons of our method with other approaches
will be made; the accuracy of the reported protein P -value will be
illustrated. Some technical but important issues will be addressed
in the discussion section. To keep the paper focused, we relegate
to supplementary information figures and tables that complement or
corroborate the information contained in the main text.
2 METHODS
2.1 Statistical Protocols
Weighting the contribution of each peptide in protein identification is
important. It helps mitigate the issue of peptide degeneracy, where an
identified peptide is a subsequence of multiple database proteins. The
optimal weighting scheme, however, can depend on the protein ID
methodology employed. For the purpose of our study, namely, devising a
method that yields accurate protein P -values, we opt for a simple weighting
scheme: a peptide’s weight is inversely proportional to the number of
database proteins it maps to. Within a sample, when multiple spectral
searches identify the same peptide but with different significance levels,
only the most significant assignment of that peptide is retained for further
analyses.
The foundation of our method is built upon a rigorous formula (Mathai,
1983; Alves and Yu, 2011) that enables weighted combination of P -values.
When the weights are all identical, this formula reduces to Fisher’s
formula (Fisher, 1932; Bahrucha-Reid, 1960); when the weights are all
different, this formula reduces to the formula of Good (Good, 1955).
A detailed derivation and generalization to incorporating nearly identical
weights can be found in (Alves and Yu, 2011), whose notation will be used
to briefly summarize the content of the formula.
Let us assume that a given protein contains L identified peptides with
P -values. Let us further group these L peptides, according to the number
of database proteins a peptide maps to, into m groups with 1 ≤ m ≤ L.
Within each group k, the nk peptide P -values are weighted equally; while
peptide P -values in different groups are weighted differently.
The weighting enters our formalism through the following quantities of
interest
τ ≡
m∏
k=1

 nk∏
j=1
pk;j


wk
, (1)
Q ≡
m∏
k=1

 nk∏
j=1
xk;j


wk
, (2)
where each pk;j represents a reported peptide P -value, each xk;j represents
a random variable drawn from an uniform, independent distribution over
(0, 1] and each wk is a positive weight. The quantity of interest Prob(Q ≤
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τ), representing the protein P -value, was obtained earlier (Alves and Yu,
2011) and is repeated below for clarity.
Let F (τ) ≡ Prob(Q ≤ τ), one may show that
F (τ) =
[
m∏
l=1
r
nl
l
]
m∑
k=1
∑
G(k)
{
1
r
gk+1
k
H(−rk ln τ , gk)×
×
( m∏
j=1,j 6=k
(nj − 1 + gj)!
(nj − 1)!gj !
(−1)gj
(rj − rk)
nj+gj
)}
, (3)
where rk ≡ 1/wk is the number of proteins a group-k peptide maps to,∑
G(k) enumerates each set of nonnegative integers {g1, g2, . . . , gm} that
satisfies the k-dependent constraint
∑m
i=1 gi = nk − 1, and the function
H is defined as
H(x, n) ≡ e−x
n∑
k=0
xk
k!
. (4)
See the supplementary information for an example application of
formula (3).
When searching a database with a prescribed peptide mass error tolerance
δ, one often needs to score different numbers of database peptides for spectra
with different precursor ion masses. That is, the number of tested hypotheses
(database peptides in the mass range [mp − δ,mp + δ]) varies by the
precursor ion mass mp. The effect of varying number of multiple hypotheses
tested can be properly accounted for by using the peptide DPVs (Yu et al.,
2006; Alves et al., 2008b) for P -values (pk;j) in eq. (1); given a quality
score cutoff Sc, the peptide DPV is defined as
Pdb(Sc) = 1− e
−E(Sc) , (5)
where E(Sc) represents the expected number of peptides having score S ≥
Sc, and the DPV Pdb(Sc) represents the probability of seeing one or more
peptides in a given random database with quality scores S ≥ Sc. Another
advantage of using DPV is that as a function of the quality score S, the
E-value E(S), determined by the search score histogram per spectrum and
the number of qualified peptides (database-dependent), correctly takes into
account both the spectrum-specificity and the database-specificity of scoring
statistics.
Since the E-value specifies the expected number of random database
peptides having scores equal to or better than the given cut-off, a peptide
with E-value larger than one is more likely to be a false positive than a
true positive. For this reason, when constructing the evidence peptide set for
identification of a protein, we only include peptides with E-values less than
one. This implies that only peptide DPVs less than (e−1)/e are considered,
leading to a combination of truncated P -values. Unfortunately, combining
truncated P -values, even though doable, is far more complicated than using
eq. (3). However, two observations simplify the matter. First, it is evident
from eq. (5) that the DPV approaches theE-value when the E-value is small.
Second, we note that confidently identified proteins must contain evidence
peptides with high identification confidences (or small E-values). Therefore,
for practical uses, we may approximate the DPV by its corresponding E-
value. Because onlyE-values less than one are considered, the approximated
DPVs (or simply the E-values) now encompass the full range between zero
and one. Consequently, it is unnecessary to combine truncated P -values,
and the simple formula (3) becomes applicable. The protein E-value is then
obtained via multiplying the protein P -value by a Bonferroni correction
factor; in this case, the Bonferroni factor is the number of protein clusters
(described below) each having at least one evidence peptide with E-value
less than one.
We denote by a protein cluster a group of entangled proteins that share a
substantial portion of evidence peptides. To avoid exaggerating the number
of identified proteins, several existing methods (Huang et al., 2012) report
those entangled proteins as one. Adopting the same idea, we implemented
this strategy via a transitive approach described below. One first sorts
the identified proteins by the number of identified evidence peptides in
descending order and using the rank of a protein in the sorted list as that
protein’s cluster index. Starting with the first protein as the reference protein,
all other lower-ranking proteins sharing at least 95% of evidence peptides
with the first protein will have their cluster indexes changed to that of the
reference protein. One then moves the reference point (from the first) to
the second protein, all other lower-ranking proteins sharing at least 95% of
evidence peptides with the reference protein will have their cluster indexes
changed to that of the reference protein. The reference point is then moved
to the third protein and the process continues till the reference point moves
through all proteins in the list. The protein with most significant P -value
within a cluster (containing one or more proteins) is called the head of
that cluster, the other proteins members of that cluster. An exception to
the aforementioned clustering rule, however, is introduced to appropriately
emphasize a protein’s evidence peptides that are not shared by other proteins.
We call evidence peptides of this kind unique peptides to a protein. When a
protein has a unique evidence peptide with E-value less than 10−4, our
method doesn’t allow this protein to be a member protein of any cluster.
2.2 MS/MS Datasets
Sixty-three spectral datasets were categorized into four data groups. See
supplementary tables (Table S1 to S4) for details. Protein mixtures giving
rise to spectral datasets were reduced with iodoacetamide, resulting in
the addition of the carbamidomethyl group (57.07 Da) to cystine residues.
Each protein mixture was further digested with trypsin. Among these
spectral datasets, there are also dataset-specific parameters such as the
target database, the maximum number of missed cleavage sites allowed, the
precursor-ion mass error tolerance and the product-ion mass error tolerance.
The dataset-specific parameters are given in the figure caption to provide
more information underlying the generation of the figures.
For brevity, we shall denote the MS/MS spectra obtained from a sample
by SN followed by its sample index. For example, SN1 denotes the
collection of MS/MS spectra acquired from mixture sample one. The first
data group, SN1 through SN15, contained MS/MS spectra from replicates
of different dilutions of Sigma49, a protein standard mixture composed of
49 know human proteins. The second data group, SN16 through SN26,
was downloaded from the Pacific Northwest National Laboratory and
contained spectra from eleven whole-cell-lysate samples of protein mixtures
of Escherichia coli K-12. The third data group, SN27 through SN30,
consisted of spectra from four in-house whole-cell-lysate samples of protein
mixtures of Escherichia coli K-12. Downloaded from PeptideAtlas database,
the fourth data group (SN31 through SN63) was composed of spectra from
SDS-PAGE protein fractionation extractions of human lung cells.
2.3 Protein Databases and Random Databases
Because protein mixtures from Escherichia coli K-12 and Homo sapiens
were analyzed using their corresponding MS/MS spectra, protein
databases for both organisms were thus required. From UniProt
http://www.uniprot.org/downloads, we downloaded 4,303 non-redundant
protein sequences of Escherichia coli K-12. A non-redundant Homo sapiens
protein database, containing 31, 236 protein sequences, was obtained from
the NCBI site ftp://ftp.ncbi.nlm.nih.gov/refseq/H sapiens/mRNA Prot/.
When analyzing statistical significance, it is often required to have
random (decoy) databases in addition to the organismal (target) databases.
One common problem when using random databases is that for a given
precursor ion mass the numbers of qualified peptides in the random database
and in the organismal database may significantly differ. This causes an
additional uncertainty in assessing statistical significance (Elias and Gygi,
2007; Wang et al., 2009). We can avoid this problem by ensuring that
the numbers of qualified peptides per spectrum are identical for both
the random and the organismal databases: for each qualified peptide in
the organismal database, we generate a corresponding random peptide by
randomly shuffling its amino acids.
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3 RESULTS
The results will be described in the following order. First, we
illustrate that our E-value assignments are accurate at both the
peptide and the protein levels. We further show that using the
formula proposed by Soric´ (1989), our reported PFDs agree well
with the target-decoy PFDs. Second, our protein E-value accuracy
is compared with that of using the formulas in (Spirin et al., 2011).
By extending the formula of Soric´ for the method of Spirin et al.
(2011), we also evaluate the agreement between their reported PFDs
and the target-decoy PFDs. Benchmarking with some of the existing
protein ID methods will be described in the third part.
3.1 E-value accuracy
The input peptide DPVs for our protein ID method are obtained via
eq. (5) using the E-values reported by RAId DbS. For this reason,
the input peptide DPVs (for protein ID) are synonymous with the
reported peptide DPVs (from RAId DbS). As mentioned earlier, the
statistical accuracy of our protein ID method relies on the DPVs
for the evidence peptides being accurate. We therefore start by
comparing the input peptide DPV with its definition. In panel A of
Figure 1, the abscissa records the peptide DPV, while the ordinate
displays the observed DPV (i.e., fraction of spectra having at least
one or more matching peptides with reported DPVs smaller than the
specified threshold). The agreement between the observed DPV and
the reported DPV indicates that the peptide DPVs used as input for
our protein ID method are accurate.
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Fig. 1. Assessment of E-value accuracy. In panels A, B, and C, the closer
the displayed curves are to the y = x line the better. In panel D, the closer
the two displayed curves are to each other the better. See section 3.1 for
more details. For panels A, B, and C, spectral dataset SN 26 (Escherichia
coli K-12 whole cell lysate) is used to search the Escherichia coli database
with mass accuracy ± 0.033 Da. for precursor and product ions. For panel
D, spectral datasets SN 13-15 (Sigma49 protein standard mixture) is used to
search the Homo sapiens database with precursor ion accuracy ± 0.033 Da.
and product ion accuracy ± 0.8 Da.
To assess whether approximating peptide DPVs by their
corresponding E-values for E-values less than one is reasonable
or not, we plot in panel B of Figure 1 the observed peptide
DPVs versus E-values. As expected, when E-values are close
to one, there is certain degree of disagreement; while for small
E-values, the agreement is excellent. To assess the accuracy of
the protein P -values reported by our eq. (3), we compare them
with the observed protein P -values. As described in the method
section, the reported proteins appear in clusters, each represented
by a head protein and its P -value. The observed protein P -value is
defined as the fraction of identified protein clusters (whose member
proteins each containing at least one evidence peptide with E-
value less than one) that have reported P -values smaller than a
given threshold. As shown in panel C of Figure 1, good agreement
between the reported protein P -value and the observed protein P -
value is obtained, indicating that our reported protein P -values are
accurate. More protein P -value accuracy assessment examples can
be found in Supplementary Figures S1, S2, and S3. With an accurate
protein P -value, one can also obtain its corresponding protein E-
value by multiplying it by the total number of protein clusters. In
Supplementary Figure S4, we show that reported protein E-values
obtained this way are accurate.
By having accurate protein E-values, one can avoid the
uncertainty associated with using a decoy database (Gupta et al.,
2011) while estimating the proportion of false discoveries. In
panel D of Figure 1, we plot two PFD curves: one is computed
using the reported protein E-value to estimate the number of false
identifications (hence the PFD), while the other is computed using
the observed PFD obtained from known target protein content in the
sample (Sigma49). The excellent agreement between the observed
PFD and the reported PFD indicates that one should be able to trust
the PFD estimated from accurate reported protein E-values. More
accuracy assessment examples of the reported PFD can be found in
Supplementary Figure S5.
3.2 Comparison with an EVD-based method
Since the method of Spirin et al. (2011) is closest to ours, we also
implemented their method and compute equivalent quantities for
comparison. Following the Supplementary Material of (Spirin et al.,
2011), we have implemented 100 random databases each containing
10,000 random amino acid sequences. However, instead of
generating sequences of uneven length, we opt for uniform
length (each sequence is of length 350) and generate these
random sequences using the background amino acid frequencies of
Robinson and Robinson (1991). The EVD parameters are obtained
by using only the best score per database search and by applying
standard procedures described in (Spirin et al., 2011). The effect of
database size difference, leading to rescaling of the α parameter, is
done the same way as in (Spirin et al., 2011).
A moment of reflection reveals that the best match P -value
of (Spirin et al., 2011) is in fact the DPV (Yu et al., 2006;
Alves et al., 2008b). We therefore plot in panel A of Figure 2 the
reported peptide DPVs against the observed peptide DPVs. The
result indicates that the peptide DPV reported by Spirin et al. (2011)
is quite accurate, with an uncertainty of a factor of 2 as reported
by Spirin et al. (2011).
To have a fair assessment, the same procedure for clustering
proteins is also applied to the proteins identified using protocols
of Spirin et al. (2011). The observed protein P -value is defined
similarly. Database proteins that contain any of the best match
peptides, one from each spectrum, form the effective protein set.
The observed protein P -value is simply the fraction of proteins
in the effective protein set that have reported protein P -values
4
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Fig. 2. Statistical Accuracy Comparison. Except that results from two methods are being displayed, panels A, B, and C display similar information
respectively to panels A, C and D of Fig. 1. See text in section 3.2 for more details.
less than the specified threshold. The reported protein P -value
for the head protein of each cluster is obtained by applying the
iterative procedure (involving uses of Stouffer’s formula) described
in (Spirin et al., 2011). In panel B of Figure 2, the reported protein
P -values are plotted against the observed protein P -values. The
agreement between the reported protein P -values and the observed
protein P -values is not as great as in the peptide case. The protein
E-value is then obtained by multiplying the protein P -value by the
total number of proteins in the effective protein set.
To construct a PFD curve, it is necessary to estimate the number
of false identifications at a given significance threshold. The number
of false identifications can be estimated either by using the reported
protein E-values or the number of identifications within the decoy
databases. The latter is currently widely used mainly because
accurate protein E-values (or P -values) are generally hard to attain.
To investigate the agreement between the PFD curves obtained using
decoy databases and using reasonably accurate protein P -values,
we use spectra acquired from dataset SN 26 and construct the
PFD curves obtained using both approaches. The good agreement
between our E-value based PFD (Soric´, 1989) and the target-decoy
based PFD, displayed in panel C of Figure 2, is expected because,
as shown in panel D of Figure 1, we have already found that the
reported PFD and the observed PFD (computed by using a known
protein mixture) are nearly identical. The disagreement between
the E-value based PFD and the target-decoy based PFD using
protocols of (Spirin et al., 2011) seems to indicate that the moderate
uncertainty in DPV can influence the accuracy of the overall PFD
estimate in a substantial manner.
For RAId DbS, the agreement between our E-value based
PFD and the target-decoy based PFD is further tested using
more spectral datasets (SN16-SN25), see supplementary Figure
S6. In addition to RAId score, RAId aPS allows other scoring
functions: XCorr, Hyperscore, and Kscore. For completeness, we
plot their corresponding protein P -value accuracy assessments in
supplementary Figures S7-S9; we also present the agreement tests
between their E-value based PFDs and the target-decoy based PFDs
in supplementary Figures S10-S12.
3.3 Comparison with other methods
The previous two subsections focus on the accuracy of type-I error
control. Although it is possible to accurately control type-I error
for some protein ID methods, this seems not the central focus of
all protein ID methods. Many protein ID methods prefer to use the
decoy database search results to pragmatically provide statistical
significances for retrieval results from the target (organismal)
database. When this approach is used, the retrieval results are
displayed in terms of a parametric PFD plot: the parameter is some
kind of significance score used to prioritize the identifications, the
abscissa shows the proportion of false discovery and the ordinate
displays the number of identifications found in the target database.
In general, a large number of target identifications at a small PFD
value indicates a good retrieval, provided that the number of decoy
identifications accurately reflects the number of false identifications
in the target database. However, one should note that the fulfillment
of the aforementioned condition requires accurate type-I error
control. Investigating and improving the statistical accuracy of type-
I error control of existing protein ID methods is beyond the scope
of this paper and we believe that it is best done by developers of
individual protein ID software.
To examine how our method compares with others under the
pragmatic target-decoy approach, we analyze two large datasets
from E. Coli (SN 27-30) and Homo Sapiens (SN 31-63) using
a variety of protein ID software along with a number of scoring
functions. The list of software is given below (with both software
version and scoring functions, if given, shown inside a pair
of parentheses): RAId DbS (v. Jan.12.2014; RAId), RAId aPS
(v. Jan.12.2014; XCorr, Kscore, Hyperscore), Mascot (v. 2.4.0,
http://www.matrixscience.com/help.html), and X!Tandem
(v. 2013.06.15; Hyperscore). The peptide identification software
SEQUEST (Eng et al., 1994) (v. 28) is only used in conjunction
with other post-processing protein ID software. We list below the
post-processing software used (with software version, peptide ID
software, and peptide scoring functions, if given, shown inside a
pair of parentheses): iProphet (v. TPP 4.5; X!Tandem; Kscore),
Proteome Discoverer (v. 1.3, http://www.thermofisher.com
/en/home.html; SEQUEST, Mascot), and Scaffold Q+/Q+S
(v. 4.0, http://www.proteomesoftware.com; SEQUEST,
Mascot). The results are displayed in different panels of Figure 3.
Before delving into the details of the results, we first provide the
information relevant to the generation of the results.
In terms of peptide identification, RAId DbS, RAId aPS,
Mascot, SEQUEST, and X!Tandem used the same parameters: for
Escherichia coli whole cell lysate, SN 27-30, the precursor ion mass
error tolerance is ± 0.033 Da., the product ion mass error tolerance
is ± 0.033 Da., and up to 5 missed cleavages are allowed; for Homo
sapiens heart cells, SN 31-63, the precursor ion mass error tolerance
is ± 1.4 Da., the product ion mass error tolerance is ± 0.4 Da., and
up to 2 missed cleavages are allowed.
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Fig. 3. Retrieval results of various methods based on their stated PFD values. Because we can only ensure the accuracy of type-I error of the proposed
method, this figure only illustrates how our retrieval fares at the stated value when compared to other methods. See the text of section 3.3 for more details. To
avoid clutter, results from using samples of Escherichia coli whole cell lysyte, SN 27-30, are displayed in three panels (A, B, and C). Within each panel, the
results from RAId DbS are always shown as a reference curve. Similarly, results from using samples of Homo sapiens heart cells, SN 31-63, are also displayed
in three panels (D, E, and F). The iProphet (Shteynberg et al., 2011) results in panel E were downloaded from PeptideAtlas instead of being computed.
Both X!Tandem and Mascot have built-in protein ID capability,
and the target-decoy approach was directly applied to estimate the
protein level PFD. The peptide ID outputs from SEQUEST and
Mascot were also further analyzed using Proteome Discoverer for
protein identification and the target-decoy approach was applied
to estimate PFD. For iProphet, we did not compute the PFD but
downloaded the results for data group 4 from PeptideAtlas. Peptide
identification in this case was done using X!Tandem (v. 2009.10.01;
Kscore).
Whenever the decoy peptide search results are available, Scaffold
computes the PFDs using the target-decoy approach; otherwise, it
computes the PFDs using a probabilistic method. In Figure 3 three
Scaffold PFD curves are displayed, two of which (shown in triangles
and circles) are from target-decoy approaches. The protein PFDs
under Scaffold were computed by fixing the peptide threshold at
20% PFD with a minimum of 1 evidence peptide per protein. We
observed that changing the peptide threshold to lower values had a
small effect on the number of proteins identified. We thus used the
minimum of 1 peptide per protein to maintain consistency across all
methods. For RAId DbS and RAId aPS, the PFD estimates do not
require user-added target-decoy methods. RAId DbS and RAId aPS
compute the PFDs using the Soric´ formula (Soric´, 1989).
Examinations of different panels of Figure 3 indicates that the
retrieval efficacy of the proposed method (shown in RAId DbS
and RAId aPS PFD curves) is comparable with existing protein ID
methods, even though only at the stated values. However, it should
be noted that the proposed method does have a few advantages.
First, it reports accurate protein P -values, providing accurate type-I
error control. Second, the PFD curves obtained using this method
show stability across different mass resolution requirement and data
sets, while some methods seem to exhibit fluctuations of notable
amplitudes.
4 DISCUSSION
Our investigation indicates that it is possible to achieve faithful
protein P -value assignment, hence accurate type-I error control, in
protein identifications. Since our approach is founded on a derived
mathematical formula that requires accurate peptide E-values as
input, it is evident that accurate protein P -values require accurate
statistical significance at the peptide identification level.
The discrepancy between the computed protein P -value and the
PFD results in our implementation of the method of Spirin et al.
(2011) is interesting. Based on the results in Fig. 2, the peptide
P -values are reasonably accurate albeit exhibiting slightly larger
fluctuations than the results from RAId DbS. In addition to the
possibility of accumulating uncertainty of peptides’ P -values, the
other possibility is that the iterative procedure to choose the
combination yielding the most significant Z-score may skew the
P -values towards the significant side. Investigation of the origin
of the PFD and P -value discrepancy when using the method
of Spirin et al. (2011), however, is beyond the scope of the
current study and might be most appropriately done by the authors
of (Spirin et al., 2011).
As explained earlier, we allow more than one candidate peptide
per spectrum to accommodate the possibility of peptide co-elution.
However, readers may ask why do we choose to use DPVs for lower-
ranking peptides per spectrum instead of using ordered statistics.
The reason is that in this context using ordered statistics beyond
the first is not meaningful: the nth ordered statistics assumes
that for a given query spectrum the best n − 1 scored peptides
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are spurious while the rank-n peptide is the underlying peptide
whose fragmentation yields the query spectrum. This contradicts the
general idea of using a scoring function: among candidate peptides
of a query spectrum, the better a peptide scores the more likely it is
the underlying peptide. On the other hand, when using the DPV for
the rank-n peptide, we are essentially assuming that the top n − 1
candidate peptides of the query spectrum are co-eluted underlying
peptides and are not considered to be spurious.
The protein identification method proposed in this paper
illustrates the possibility of accurate type-I error control, providing
a theoretically sound significance assignment method that is also
pragmatically simpler than the target-decoy approach. This is
particularly important since the number of identified proteins versus
PFDs provides trustworthy retrieval results only if the reported
PFDs truly reflects the proportion of false discoveries. Evidently,
to achieve accurate type-I error control is a task best done by
developers of individual software. Only when this is accomplished
can a true retrieval comparison among different methods be done.
Since we did not focus on type-II error, there is definite room
for improvement in terms of retrieval efficacy. We note that the
information of negatives (segments of a candidate protein not
covered by the protein’s evidence peptides) is not used. We also
believe that, in principle, scoring functions for peptide identification
can also be improved to better separate true underlying peptides
from false positives. Currently, we are using a flat peptide weight
(by the number of proteins a peptide covers). It is perceivable that
more sophisticated weighting may be useful in better separating true
positive proteins from false positives. It is our plan to investigate
these avenues of improvement in the near future.
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SUPPLEMENTARY INFORMATION
Example application of formula (3) of the main text
To illustrate the use of the formula used to compute a protein P -value, let us consider the following toy example. Let protein Π have six
peptide evidences pi1, pi2, . . . , pi6 that falls into three groups {pi1}, {pi2, pi3}, and {pi4, pi5, pi6}, respectively with weights 1, 1/3, 1/2. This
means that peptide pi1 is a subsequence of protein Π only, peptides pi2 and pi3 are subsequences of three proteins (Π and two others), and
peptides pi4, pi5, and pi6 are subsequences of two proteins (Π and another one). Let the peptide E-values of these six evidence peptides be
e1, e2, . . . , e6, all less than one. Under our approximating database P -value by E-value, this means that the evidence peptides have their
respective database P -values e1, e2, . . . , e6. From the information above we know that m = 3, n1 = 1, n2 = 2, n3 = 3, w1 = 1,
w2 = 1/3, w3 = 1/2, r1 = 1/w1 = 1, r2 = 1/w2 = 3, and r3 = 1/w3 = 2.
To use formula (3) in the manuscript to compute a protein P -value, we first need the quantity τ given by eq. (1) in the main text. In the
current case– m = 3, n1 = 1, n2 = 2, n3 = 3 and with peptides database P -values e1, e2, . . . , e6 – the quantity τ can be written as
τ =
3∏
k=1
[
nk∏
j=1
ek;j
]wk
= ew11 e
w2
2 e
w2
3 e
w3
4 e
w3
5 e
w3
6 .
And the protein P -value is given by
F (τ ) =
[
3∏
l=1
rnll
]
3∑
k=1
∑
G(k)
{
1
rgk+1k
H(−rk ln τ , gk)×
( 3∏
j=1,j 6=k
(nj − 1 + gj)!
(nj − 1)!gj !
(−1)gj
(rj − rk)nj+gj
)}
, (6)
where H(−rk ln τ , gk) is given by
H(−rk ln τ , gk) = exp(rk ln τ )
gk∑
k=0
(−rk ln τ )
k
k!
.
Remember that
∑
G(k) enumerates each set of nonnegative integers {g1, g2, . . . , gm} that satisfies the k-dependent constraint
∑m
i=1 gi =
nk − 1, it is thus possible to replace the
∑
G(k) in eq. (6) by an m-dimensional summation with an explicit constraint. Specifically, we can
rewrite the sum over set as
F (τ ) =
[
3∏
l=1
rnll
]
3∑
k=1
nk−1∑
g1=0
nk−1∑
g2=0
nk−1∑
g3=0
δg1+g2+g3,nk−1
{
1
rgk+1k
H(−rk ln τ , gk)×
×
( 3∏
j=1,j 6=k
(nj − 1 + gj)!
(nj − 1)!gj !
(−1)gj
(rj − rk)nj+gj
)}
. (7)
where the Kronecker delta function δn,n′ takes value one if n = n′ but zero otherwise.
The first product on the right hand side of eq. (7) is equal to[
3∏
l=1
r
nl
l
]
= (r1)
1 · (r2)
2 · (r3)
3 = 11 · 32 · 23 .
After this overall factor is obtained, the main task is to evaluate the summation over k, which ranges from k = 1 to k = 3. For each k, we
are only interested in the non-negative integral gis that satisfy the k-dependent constraint
∑3
i=1 gi = nk − 1. When k = 1 we have n1 = 1
and the constrained summation
0∑
g1=0
0∑
g2=0
0∑
g3=0
δg1+g2+g3,0
only allows one valid {g1, g2, g3} set, namely, {0,0,0}. For k = 2 we have n2 = 2 and the constrained summation
1∑
g1=0
1∑
g2=0
1∑
g3=0
δg1+g2+g3,1
allows three sets of valid {g1, g2, g3}, namely, {1,0,0}, {0,1,0} and {0,0,1}. For k = 3 we have n3 = 3 and the constrained summation
2∑
g1=0
2∑
g2=0
2∑
g3=0
δg1+g2+g3,2
allows six sets of valid {g1, g2, g3}, namely, {1,1,0}, {1,0,1}, {0,1,1}, {2,0,0}, {0,2,0} and {0,0,2}. Each valid set of {g1, g2, g3} must be
substituted into the summand (inside the pair of curly braces) of eq. (7) to yield its respective contribution for the P -value.
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Supplementary Tables
Table S1. MS/MS data group 1. The corresponding spectral datasets are produced by using Sigma49 (a protein standard mixture
composed of 49 known human proteins), and are downloaded from the National Center for Biotechnology Information (Peptidome database)
at ftp://ftp.ncbi.nih.gov/pub/peptidome/studies/PSEnnn/PSE108. The column heading SN represents sample index, the abbreviation CGL stands for
chromatography gradient length, and the column heading ns stands for the number of spectra acquired. The rest of the column headings are self-explanatory.
SN Sample Load Instrument CGL(minutes) ns File Name
1 5 fmol LTQ Orbitrap 45 1,531 PSM1027 07FEB15 ABRF FT 5a.mzXML
2 5 fmol LTQ Orbitrap 45 1,902 PSM1028 07FEB15 ABRF FT 5b.mzXML
3 5 fmol LTQ Orbitrap 45 2,014 PSM1029 07FEB15 ABRF FT 5c.mzXML
4 10 fmol LTQ Orbitrap 45 2,026 PSM1027 07FEB15 ABRF FT 10a.mzXM
5 10 fmol LTQ Orbitrap 45 2,125 PSM1028 07FEB15 ABRF FT 10b.mzXML
6 10 fmol LTQ Orbitrap 45 2,253 PSM1029 07FEB15 ABRF FT 10c.mzXML
7 25 fmol LTQ Orbitrap 45 2,772 PSM1027 07FEB15 ABRF FT 25a.mzXML
8 25 fmol LTQ Orbitrap 45 2,669 PSM1028 07FEB15 ABRF FT 25b.mzXML
9 25 fmol LTQ Orbitrap 45 2,504 PSM1029 07FEB15 ABRF FT 25c.mzXML
10 50 fmol LTQ Orbitrap 45 3,259 PSM1027 07FEB15 ABRF FT 50a.mzXML
11 50 fmol LTQ Orbitrap 45 3,406 PSM1028 07FEB15 ABRF FT 50b.mzXML
12 50 fmol LTQ Orbitrap 45 2,993 PSM1029 07FEB15 ABRF FT 50c.mzXML
13 100 fmol LTQ Orbitrap 45 3,629 PSM1027 07FEB15 ABRF FT 100a.mzXML
14 100 fmol LTQ Orbitrap 45 3,622 PSM1028 07FEB15 ABRF FT 100b.mzXML
15 100 fmol LTQ Orbitrap 45 3,592 PSM1029 07FEB15 ABRF FT 100c.mzXML
Table S2. MS/MS data group 2. The corresponding spectral datasets are produced by using a complex protein mixture of Escherichia coli K-12 whole cell
lysate, and are downloaded from the Pacific Northwest National Laboratory at http://omics.pnl.gov/.
SN Instrument CGL(minutes) ns File Name
16 LTQ Orbitrap 100 18,573 Ecoli432 R1-rr 18Dec09 Falcon 09-09-14.mzXML
17 LTQ Orbitrap 100 18,585 Ecoli432 R2 7Dec09 Falcon 09-09-15.mzXML
18 LTQ Orbitrap 100 18,669 Ecoli432 R3 7Dec09 Falcon 09-09-16.mzXML
19 LTQ Orbitrap 100 18,585 Ecoli432 R4 15Dec09 Falcon 09-09-16.mzXML
20 LTQ Orbitrap 100 18,650 Ecoli433 R1 7Dec09 Falcon 09-09-14.mzXML
21 LTQ Orbitrap 100 18,763 Ecoli433 R2 7Dec09 Falcon 09-09-15.mzXML
22 LTQ Orbitrap 100 18,770 Ecoli433 R4 13Dec09 Falcon 09-09-16.mzXML
23 LTQ Orbitrap 100 18,488 Ecoli434 R1 7Dec09 Falcon 09-09-14.mzXML
24 LTQ Orbitrap 100 18,923 Ecoli434 R2 7Dec09 Falcon 09-09-15.mzXML
25 LTQ Orbitrap 100 19,010 Ecoli434 R3 7Dec09 Falcon 09-09-16.mzXML
26 LTQ Orbitrap 100 18,737 Ecoli434 R4 13Dec09 Falcon 09-09-16.mzXML
Table S3. MS/MS data group 3. The corresponding spectral datasets are produced by using a complex protein mixture of Escherichia coli whole cell lysate
prepared in house.
SN Instrument CGL(minutes) ns File Name
27 Orbitrap Elite 90 24,280 E L 2.mzML
28 Orbitrap Elite 90 22,435 E M 2.mzML
29 Orbitrap Elite 90 23,875 E H 2.mzML
30 Orbitrap Elite 90 18,573 E S 2.mzML
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Table S4. MS/MS data group 4. The corresponding spectral datasets are produced by using SDS-PAGE protein fractionation extraction of human lung cells,
and are downloaded from PeptideAtlas database at ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/PAe001771.
SN Instrument CGL(minutes) ns File Name
31-63 LTQ Orbitrap 120 340,861 Roche human lung 001.mzML - Roche human lung 033.mzML
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Supplementary Figures
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Fig. S1. Accuracy assessment of the protein P-value reported by the proposed method using data group 1 and RAId DbS’s peptide E-values. All
spectra in data group 1 are used to search the Homo sapiens database with precursor-ion mass tolerance ± 0.033 Da., product-ion mass tolerance ± 0.8 Da.
and up-to-2 missed cleavage sites allowed. The accuracy of the reported protein P-value is evaluated by plotting it versus the observed protein P-value, see
main text for details. The closer the above curves are to the y = x line the more accurate are the reported protein P-values. The two dash lines, y = 2x and
y = 0.5x, are provided as visual guides regarding how close/off the reported protein P-values are to the y = x line.
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Fig. S2. Accuracy assessment of the protein P-value reported by the proposed method using data group 2 and RAId DbS’s peptide E-values. All
spectra in data group 2 are used to search the Escherichia coli database with precursor-ion mass tolerance ± 0.033 Da., product-ion mass tolerance ± 0.033
Da. and up-to-2 missed cleavage sites allowed. The accuracy of the reported protein P-value is evaluated by plotting it versus the observed protein P-value,
see main text for details. The closer the above curves are to the y = x line the more accurate are the reported protein P-values. The two dash lines, y = 2x
and y = 0.5x, are provided as visual guides regarding how close/off the reported protein P-values are to the y = x line.
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Fig. S3. Accuracy assessment of the reported protein P-value by the proposed method when the mass tolerances are very small. The protein P -values
are obtained by using RAId DbS’s peptide E-values. All spectra in data group 2 are used to search the Escherichia coli database with precursor-ion mass
tolerance ± 0.0033 Da., product-ion mass tolerance ± 0.0033 Da. and up-to-2 missed cleavage sites allowed. The accuracy of the reported protein P-value is
evaluated by plotting it versus the observed protein P-value, see main text for details. The closer the above curves are to the y = x line the more accurate are
the reported protein P-values. The two dash lines, y = 2x and y = 0.5x, are provided as visual guides regarding how close/off the reported protein P-values
are to the y = x line.
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Fig. S4. Accuracy assessment of the protein E-value reported by the proposed method using data group 1 and RAId DbS’s peptide E-values. All
spectra in data group 1 are used to search the Homo sapiens database with precursor-ion mass tolerance ± 0.033 Da., product-ion mass tolerance ± 0.8 Da.
and up-to-2 missed cleavage sites allowed. The accuracy of the reported protein P-value is evaluated by plotting it versus the observed protein P-value, see
main text for details. The closer the above curves are to the y = x line the more accurate are the reported protein E-values. The two dash lines, y = 2x and
y = 0.5x, are provided as visual guides regarding how close/off the reported protein E-values are to the y = x line.
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Fig. S5. Accuracy assessment of reported protein PFD using data group 1 and RAId DbS’s peptide E-values. All spectra in data group 1 (MS/MS
spectra from SN 1-15) are used to search the Homo sapiens database with precursor-ion mass tolerance ± 0.033 Da., product-ion mass tolerance ± 0.8 Da.
and up-to-2 missed cleavage sites allowed. The reported PFD is computed by using the reported protein E-value in Soric´’s formula, while the observed PFD is
obtained from the ratio of the number of false discoveries (false positives) to the total number of discoveries (true positives + false positives) at a given E-value
cutoff. The closer the observed and reported curves are to each other the better.
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Fig. S6. The agreement between the E-value based PFD and the target-decoy based PFD when the peptide E-values are from RAId DbS. All spectra
in data group 2 (MS/MS spectra SN16-26) are used to search the Escherichia coli database with precursor-ion mass tolerance ± 0.033 Da., product-ion mass
tolerance ± 0.033 Da. and up-to-2 missed cleavage sites allowed. The E-value based PFD is computed by using the reported protein E-value in Soric´’s
formula, while the target-decoy based PFD is obtained from the ratio of the number of identified decoy proteins to the total number of identified proteins
(target + decoy) for a given E-value cutoff. Within each panel, the closer the two curves are to each other the better.
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Fig. S7. Accuracy assessment of the protein P-value using data group 2 and RAId aPS’s peptide E-values when the selected scoring function is
XCorr. All spectra in data group 2 are used to search the Escherichia coli database with precursor-ion mass tolerance ± 0.033 Da., product-ion mass tolerance
± 0.033 Da. and up-to-2 missed cleavage sites allowed. The accuracy of the reported protein P-value is evaluated by plotting it versus the observed protein
P-value, see main text for details. The closer the above curves are to the y = x line the more accurate are the reported protein P-values. The two dash lines,
y = 2x and y = 0.5x, are provided as visual guides regarding how close/off the reported protein P-values are to the y = x line.
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Fig. S8. Accuracy assessment of the protein P-value using data group 2 and RAId aPS’s peptide E-values when the selected scoring function is
Hyperscore. All spectra in data group 2 are used to search the Escherichia coli database with precursor-ion mass tolerance ± 0.033 Da., product-ion mass
tolerance ± 0.033 Da. and up-to-2 missed cleavage sites allowed. The accuracy of the reported protein P-value is evaluated by plotting it versus the observed
protein P-value, see main text for details. The closer the above curves are to the y = x line the more accurate are the reported protein P-values. The two dash
lines, y = 2x and y = 0.5x, are provided as visual guides regarding how close/off the reported protein P-values are to the y = x line.
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Fig. S9. Accuracy assessment of the protein P-value using data group 2 and RAId aPS’s peptide E-values when the selected scoring function is
Kscore. All spectra in data group 2 are used to search the Escherichia coli database with precursor-ion mass tolerance ± 0.033 Da., product-ion mass
tolerance ± 0.033 Da. and up-to-2 missed cleavage sites allowed. The accuracy of the reported protein P-value is evaluated by plotting it versus the observed
protein P-value, see main text for details. The closer the above curves are to the y = x line the more accurate are the reported protein P-values. The two dash
lines, y = 2x and y = 0.5x, are provided as visual guides regarding how close/off the reported protein P-values are to the y = x line.
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Fig. S10. The agreement between the E-value based PFD and the target-decoy based PFD when the peptide E-values are from RAId aPS(XCorr).
All spectra in data group 2 (MS/MS spectra SN16-26) are used to search the Escherichia coli database with precursor-ion mass tolerance ± 0.033 Da.,
product-ion mass tolerance ± 0.033 Da. and up-to-2 missed cleavage sites allowed. The E-value based PFD is computed by using the reported protein E-value
in Soric´’s formula, while the target-decoy based PFD is obtained from the ratio of the number of identified decoy proteins to the total number of identified
proteins (target + decoy) for a given E-value cutoff. Within each panel, the closer the two curves are to each other the better.
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Fig. S11. The agreement between the E-value based PFD and the target-decoy based PFD when the peptide E-values are from
RAId aPS(Hyperscore). All spectra in data group 2 (MS/MS spectra SN16-26) are used to search the Escherichia coli database with precursor-ion mass
tolerance ± 0.033 Da., product-ion mass tolerance ± 0.033 Da. and up-to-2 missed cleavage sites allowed. The E-value based PFD is computed by using the
reported protein E-value in Soric´’s formula, while the target-decoy based PFD is obtained from the ratio of the number of identified decoy proteins to the total
number of identified proteins (target + decoy) for a given E-value cutoff. Within each panel, the closer the two curves are to each other the better.
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Fig. S12. The agreement between the E-value based PFD and the target-decoy based PFD when the peptide E-values are from RAId aPS(Kscore).
All spectra in data group 2 (MS/MS spectra SN16-26) are used to search the Escherichia coli database with precursor-ion mass tolerance ± 0.033 Da.,
product-ion mass tolerance ± 0.033 Da. and up-to-2 missed cleavage sites allowed. The E-value based PFD is computed by using the reported protein E-value
in Soric´’s formula, while the target-decoy based PFD is obtained from the ratio of the number of identified decoy proteins to the total number of identified
proteins (target + decoy) for a given E-value cutoff. Within each panel, the closer the two curves are to each other the better.
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